The Potential of Nichi Glucan as a Vaccine Adjuvant

A paper describing the potentials of Nichi Glucan as a vaccine adjuvant to COVID-19 has been published in Human Vaccines and Immunotherapeutics, a journal sponsored by the International Society of Vaccines.

Clinical studies in Covid-19 and its variants to tackle the pandemic, recommended.

To read the press release in Business Wire, click here.

Please visit for more information about Nichi Glucan.


Other Press release

Other articles